Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply. Jones RH, Casbard A, Carucci M, Foxley A, et al. Lancet Oncol 2020;21:e234.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jones RH, Casbard A, Carucci M, Foxley A, et al. Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply. Lancet Oncol 2020;21:e234.
PMID: 32359499